Penicillin g potassium and Erythromycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Penicillin g potassium and Erythromycin. Common interactions include drug hypersensitivity among females and drug hypersensitivity among males.

The phase IV clinical study analyzes what interactions people who take Penicillin g potassium and Erythromycin have. It is created by eHealthMe based on reports of 10 people who take Penicillin g potassium and Erythromycin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

10 people who take Penicillin g potassium and Erythromycin together, and have interactions are studied.


What is Penicillin g potassium?

Penicillin g potassium has active ingredients of penicillin g potassium. It is often used in strep throat. eHealthMe is studying from 959 Penicillin g potassium users for its effectiveness, alternative drugs and more.

What is Erythromycin?

Erythromycin has active ingredients of erythromycin. It is often used in acne. eHealthMe is studying from 9,384 Erythromycin users for its effectiveness, alternative drugs and more.

Number of Penicillin g potassium and Erythromycin reports submitted per year:

Penicillin g potassium and Erythromycin drug interactions.

Common Penicillin G Potassium and Erythromycin drug interactions by gender *:

female:

  1. Drug hypersensitivity
  2. Pneumothorax traumatic
  3. Rash pruritic
  4. Renal failure acute
  5. Rib fracture
  6. Somnambulism
  7. Subarachnoid haemorrhage
  8. Ventricular fibrillation
  9. Tubulointerstitial nephritis
  10. Brain death

male:

  1. Drug hypersensitivity

Common Penicillin G Potassium and Erythromycin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Tubulointerstitial nephritis
  2. Nephritis allergic
  3. Renal failure acute

60+:

  1. Brain death
  2. Cardiac arrest
  3. Somnambulism
  4. Subarachnoid haemorrhage
  5. Ventricular fibrillation
  6. Cervical vertebral fracture
  7. Coma
  8. Drug hypersensitivity
  9. Fall
  10. Loss of consciousness

Common conditions people have *:

  1. Upper Respiratory Tract Infection: 2 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Penicillin g potassium and Erythromycin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Penicillin g potassium and Erythromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Erythromycin interactions:

Browse all interactions between Erythromycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on penicillin g potassium and erythromycin (the active ingredients of Penicillin g potassium and Erythromycin, respectively), and Penicillin g potassium and Erythromycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Penicillin g potassium and Erythromycin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: